144 related articles for article (PubMed ID: 26411549)
1. Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinoma.
Kim EH; Strope SA
Urol Oncol; 2015 Dec; 33(12):499-502. PubMed ID: 26411549
[TBL] [Abstract][Full Text] [Related]
2. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.
Stewart SB; Thompson RH; Psutka SP; Cheville JC; Lohse CM; Boorjian SA; Leibovich BC
J Clin Oncol; 2014 Dec; 32(36):4059-65. PubMed ID: 25403213
[TBL] [Abstract][Full Text] [Related]
4. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
5. Surveillance following surgery for nonmetastatic renal cell carcinoma.
Richards KA; Abel EJ
Curr Opin Urol; 2016 Sep; 26(5):432-8. PubMed ID: 27467135
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
[TBL] [Abstract][Full Text] [Related]
7. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.
Kim EH; Vetter JM; Kuxhausen AN; Song JB; Sandhu GS; Strope SA
Urol Oncol; 2016 May; 34(5):237.e11-8. PubMed ID: 26725251
[TBL] [Abstract][Full Text] [Related]
8. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
9. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
10. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
11. Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.
Zhao J; Zhu Y; Zhang C; Wang X; He H; Wang H; Wu Y; Zhou W; Shen Z
Urol Oncol; 2013 Nov; 31(8):1800-5. PubMed ID: 22658883
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Surveillance for Renal Cell Carcinoma.
Merrill SB
Urol Clin North Am; 2017 May; 44(2):313-323. PubMed ID: 28411922
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
Cohen DD; Matin SF; Steinberg JR; Zagone R; Wood CG
J Urol; 2005 May; 173(5):1487-90; discussion 1490-1. PubMed ID: 15821465
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.
Stephenson AJ; Chetner MP; Rourke K; Gleave ME; Signaevsky M; Palmer B; Kuan J; Brock GB; Tanguay S
J Urol; 2004 Jul; 172(1):58-62. PubMed ID: 15201737
[TBL] [Abstract][Full Text] [Related]
15. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
16. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
17. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?
Lin YK; Gettle L; Raman JD
BJU Int; 2013 May; 111(6):891-6. PubMed ID: 23331317
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
[TBL] [Abstract][Full Text] [Related]
20. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
